HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xuemei Sui Selected Research

Xuemei Sui Research Topics

Disease

10Cardiovascular Diseases (Cardiovascular Disease)
05/2017 - 05/2013
9Neoplasms (Cancer)
07/2017 - 08/2010
8Hypertension (High Blood Pressure)
01/2022 - 05/2008
6Obesity
07/2022 - 02/2009
5Type 2 Diabetes Mellitus (MODY)
10/2019 - 02/2009
5Heart Failure
07/2015 - 07/2009
4Insulin Resistance
12/2021 - 11/2010
4Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2014 - 06/2008
3Overweight
04/2022 - 05/2011
3Dyslipidemias (Dyslipidemia)
10/2021 - 05/2015
3Hypercholesterolemia
01/2018 - 05/2008
2Abdominal Obesity
07/2022 - 08/2010
2Inflammation (Inflammations)
10/2021 - 11/2010
2Liver Neoplasms (Liver Cancer)
10/2018 - 02/2016
2Hepatocellular Carcinoma (Hepatoma)
10/2018 - 02/2016
2Weight Loss (Weight Reduction)
09/2016 - 05/2011
2Acquired Immunodeficiency Syndrome (AIDS)
01/2014 - 05/2013
2Stroke (Strokes)
11/2011 - 10/2011
2Chronic Disease (Chronic Diseases)
03/2010 - 04/2009
2Diabetes Mellitus
09/2009 - 05/2008
1Atherosclerosis
07/2022
1Gallbladder Diseases (Gall Bladder Disease)
01/2017
1Ischemia
01/2017
1Body Weight (Weight, Body)
09/2016
1Genetic Predisposition to Disease (Genetic Predisposition)
09/2016
1Burkitt Lymphoma (Burkitt's Lymphoma)
02/2016
1Coronary Disease (Coronary Heart Disease)
07/2015
1Prediabetic State (Prediabetes)
02/2014
1Hyperglycemia
11/2011
1Hypertriglyceridemia
08/2010
1Hypokalemia
05/2010
1Diastolic Heart Failure
08/2009
1Overactive Urinary Bladder (Overactive Bladder)
07/2009
1Breast Neoplasms (Breast Cancer)
04/2009
1Chronic Renal Insufficiency
09/2006
1Systolic Heart Failure
09/2006

Drug/Important Bio-Agent (IBA)

14Glucose (Dextrose)FDA LinkGeneric
04/2022 - 05/2008
7Triglycerides (Triacylglycerol)IBA
07/2022 - 09/2014
7CholesterolIBA
07/2022 - 06/2008
5LipidsIBA
01/2022 - 11/2010
2C-Reactive ProteinIBA
07/2022 - 12/2021
2Insulin (Novolin)FDA Link
10/2019 - 01/2019
2tocophersolanIBA
10/2018 - 02/2016
2Proteins (Proteins, Gene)FDA Link
01/2017 - 11/2012
2Indicators and Reagents (Reagents)IBA
01/2017 - 10/2011
2HDL CholesterolIBA
10/2016 - 08/2010
2CoffeeFDA Link
12/2013 - 10/2013
1Biomarkers (Surrogate Marker)IBA
07/2022
1Hemoglobins (Hemoglobin)IBA
04/2022
1antineoplaston A10 (A 10)IBA
01/2022
1Sorafenib (BAY 43-9006)FDA Link
10/2018
1pluronic block copolymer P123IBA
10/2018
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2017
1A 19IBA
07/2017
1TeaIBA
05/2017
1omega-Chloroacetophenone (Mace)IBA
01/2017
1Ligases (Synthetase)IBA
01/2017
1UbiquitinIBA
01/2017
1oxidized low density lipoproteinIBA
10/2016
1LDL CholesterolIBA
10/2016
1Pharmaceutical PreparationsIBA
09/2016
1Mannitol (Osmitrol)FDA LinkGeneric
02/2016
1GenisteinIBA
02/2016
1Therapeutic UsesIBA
02/2016
1Lipoproteins (Lipoprotein)IBA
05/2015
1Biological ProductsIBA
11/2010
1PotassiumIBA
05/2010
1MagnesiumIBA
08/2009
1DiureticsIBA
07/2009
1Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA
07/2009
1Estrogens (Estrogen)FDA Link
04/2009
1Oral ContraceptivesIBA
04/2009
1Uric Acid (Urate)IBA
06/2008
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
09/2006

Therapy/Procedure

5Therapeutics
01/2019 - 07/2009
2Drug Therapy (Chemotherapy)
02/2016 - 11/2015
2Art Therapy
01/2014 - 05/2013
1Chinese Traditional Medicine (Traditional Chinese Medicine)
02/2016
1Radiotherapy
02/2016
1Cardiac Rehabilitation
07/2015
1Secondary Prevention
07/2015
1Resistance Training
10/2014
1Highly Active Antiretroviral Therapy (HAART)
05/2013
1Activities of Daily Living (ADL)
06/2012
1Wearable Electronic Devices
05/2011